CryoCor: Another Small Med Company Rallies Like Mad
by Douglas A McIntyre
24/7 Wall St.
CryoCor (CRYO) had revenue of $540,000 last year, and a loss of over $15 million. It did not do much better in 2004 or 2005. But, as of this morning, the company sports a market cap of $81 million.
Nice work, if you can find it.
CryoCor's shares are up on a deal with Boston Scientific (BSX). The two companies "are collaborating on the development of cryoablation, or extreme cold, to treat irregular heartbeat, or, cardiac arrhythmias," according to The Associated Press.
Continue article at 247WallSt.com
RELATED READING:
- Against Odds, CryoCor Gets Advisory Panel Nod
- FDA Gives CryoCor the Cold Shoulder
24/7 Wall St. is a regular contributor to BioHealth Investor
__________
24/7 Wall St.
CryoCor (CRYO) had revenue of $540,000 last year, and a loss of over $15 million. It did not do much better in 2004 or 2005. But, as of this morning, the company sports a market cap of $81 million.Nice work, if you can find it.
CryoCor's shares are up on a deal with Boston Scientific (BSX). The two companies "are collaborating on the development of cryoablation, or extreme cold, to treat irregular heartbeat, or, cardiac arrhythmias," according to The Associated Press.
Continue article at 247WallSt.com
RELATED READING:
- Against Odds, CryoCor Gets Advisory Panel Nod
- FDA Gives CryoCor the Cold Shoulder
24/7 Wall St. is a regular contributor to BioHealth Investor
__________
posted by Nico at
1:22 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home